Basilea Pharmaceutica AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0011432447
CHF
52.60
-1.4 (-2.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
127.94
81.00
-10.00
-20.71
-58.61
-102.05
Shareholder's Funds
127.94
81.00
-10.00
-20.71
-58.61
-102.05
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
77.50
97.97
112.97
170.81
218.94
241.42
Secured Loans
77.50
97.97
112.97
170.81
218.94
241.42
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-11.70
-17.33
0.00
0.00
0.00
0.00
Other Long Term Liabilities
29.4
35.3
40.25
35.35
36.92
42.01
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
8.23
10.21
15.15
8.34
24.99
27.80
Total Non-Current Liabilities
104.84
131.21
135.70
166.71
131.47
281.68
Current Liabilities
Trade Payables
15.06
11.49
5.85
0.19
10.62
13.15
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
8.23
10.21
15.15
8.34
24.99
27.80
Total Current Liabilities
49.22
45.56
47.59
74.85
174.41
50.16
Total Liabilities
282.00
257.76
173.29
220.85
247.27
229.79
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
30.00
30.37
31.50
32.09
17.50
29.35
Less: Accumulated Depreciation
11.85
11.39
10.94
10.52
14.58
24.07
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
18.15
18.98
20.55
21.57
2.92
5.28
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
23.27
2.39
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.05
0.17
0.04
0.07
0.26
0.32
Total Non-Current Assets
30.27
36.85
21.14
45.48
6.20
6.27
Current Assets Loans & Advances
Current Investments
132.70
106.71
51.83
50.00
95.00
111.67
Inventories
21.56
31.61
26.41
24.24
22.78
21.19
Sundry Debtors
13.49
8.88
27.89
33.15
24.95
8.71
Cash and Bank
29.64
17.85
12.49
36.57
54.95
55.61
Other Current Assets
247.18
214.35
148.88
172.51
237.18
220.86
Short Term Loans and Advances
49.79
49.31
30.26
28.55
39.50
23.68
Total Current Assets
251.73
220.91
152.15
175.36
241.07
223.53
Net Current Assets (Including Current Investments)
202.51
175.35
104.55
100.51
66.66
173.37
Total Current Assets Excluding Current Investments
251.73
220.91
152.15
175.36
241.07
223.53
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
282.00
257.76
173.29
220.85
247.27
229.79
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
77.50
97.97
112.97
170.81
218.94
241.42
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Basilea Pharmaceutica AG
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
127.94
448.76
-320.82
-71.49%
Shareholder's Funds
127.94
448.76
-320.82
-71.49%
Minority Interest
0
6.40
-6.40
-100.00%
Long-Term Borrowings
77.50
0.79
76.71
9,710.13%
Secured Loans
77.50
0.79
76.71
9,710.13%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-11.70
68.02
-79.72
-117.20%
Other Long Term Liabilities
29.40
90.99
-61.59
-67.69%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
8.23
0.54
7.69
1,424.07%
Total Non-Current Liabilities
104.84
91.13
13.71
15.04%
Current Liabilities
Trade Payables
15.06
10.54
4.52
42.88%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
8.23
0.54
7.69
1,424.07%
Total Current Liabilities
49.22
23.75
25.47
107.24%
Total Liabilities
282.00
570.03
-288.03
-50.53%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
30.00
83.66
-53.66
-64.14%
Less: Accumulated Depreciation
11.85
55.00
-43.15
-78.45%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
18.15
28.66
-10.51
-36.67%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
16.13
-16.13
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.05
10.64
-10.59
-99.53%
Total Non-Current Assets
30.27
399.50
-369.23
-92.42%
Current Assets Loans & Advances
Current Investments
132.70
62.24
70.46
113.21%
Inventories
21.56
9.70
11.86
122.27%
Sundry Debtors
13.49
22.46
-8.97
-39.94%
Cash and Bank
29.64
51.98
-22.34
-42.98%
Other Current Assets
247.18
147.76
99.42
67.28%
Short Term Loans and Advances
49.79
1.38
48.41
3,507.97%
Total Current Assets
251.73
170.53
81.20
47.62%
Net Current Assets (Including Current Investments)
202.51
146.79
55.72
37.96%
Total Current Assets Excluding Current Investments
251.73
170.53
81.20
47.62%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
282.00
570.03
-288.03
-50.53%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
77.50
0.79
76.71
9,710.13%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period